PAPER Latta CH, Sudduth TL, Weekman EM, Brothers HM, Abner EL, Popa GJ, Mendenhall MD, Gonzalez-Oregon F, Braun K, Wilcock DM
PAPER Collins SJ, Tumpach C, Li QX, Lewis V, Ryan TM, Roberts B, Drew SC, Lawson VA, Haigh CL25884827
PAPER Jin SC, Carrasquillo MM, Benitez BA, Skorupa T, Carrell D, Patel D, Lincoln S, Krishnan S, Kachadoorian M, Reitz C, Mayeux R, Wingo TS, Lah JJ, Levey AI, Murrell J, Hendrie H, Foroud T, Graff-Radford NR, Goate AM, Cruchaga C, Ertekin-Taner N25886450
PAPER Voyle N, Baker D, Burnham SC, Covin A, Zhang Z, Sangurdekar DP, Tan Hehir CA, Bazenet C, Lovestone S, Kiddle S, Dobson RJ25881911
PAPER Chen X, Wong A, Ye R, Xiao L, Wang Z, Lin Y, Yang F, Li H, Feng T, Duan L, Han Y, Dai Q, Du J, Xu G, Mok V, Xiong Y, Liu X
Validation of NINDS-CSN neuropsychological battery for vascular cognitive impairment in Chinese stroke patients.BMC Neurol. 2015;15(1):20. PubMed: 25886571
International Clinical Trials NetworkHouston, United States
SUNY Upstate College of MedicineSyracuse, United States
RESEARCH NEWS 2015-04-17 Research News More than a year ago, researchers identified variants in phospholipase D3 (PLD3) as risk factors for Alzheimer’s disease. First found in two families and then confirmed in several larger cohorts, the variants reportedly doubled the risk of ...
Amy Nelson, Berislav Zlokovic on BMI and risk of dementia in two million people over two decades: a retrospective cohort study.
COMMENT It is becoming more appreciated that damage to microvessels and the blood-brain barrier may kick-start Alzheimer’s disease (AD) progression. In fact, ailments affecting the neurovasculature, such as cardiovascular disease, hypertension, stroke, and ...
COMMENT MicroRNA expression profiling studies of the AD brain have yielded invaluable information about microRNAs whose expression consistently differs between healthy and diseased CNS. These findings not only shed light on regulatory mechanisms possibly ...
PAPER Shaltiel G, Hanan M, Wolf Y, Barbash S, Kovalev E, Shoham S, Soreq H
Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target.Brain Struct Funct. 2013 Jan;218(1):59-72. Epub 2012 Jan 14 PubMed: 22246100
No filters selected